Company announcement – No. 19 / 2025
Related Questions
How might the involvement of Van Herk Investments B.V. influence Zealand Pharma's governance and strategic direction?
What is the likely effect of this shareholder change on ZEAL's short‑term liquidity and trading volume?
Does the stake acquisition suggest confidence in upcoming product milestones or pipeline developments, and how could that impact the stock valuation?